Product Description
IKB alpha Polyclonal Antibody | BS65736 | Bioworld
Host: Rabbit
Reactivity: Human,Mouse,Rat,
Application: WB,IHC-P,FCM,
Application Range: WB=1:500-2000,IHC-P=1:100-500,Flow-Cyt=1ug/test
Background: Three major forms of IKB like molecules have been identified and each is characterised by multiple copies of ankyrin repeats. IKB alpha and IKB beta appear to be the major regulatory forms of IKB in most cells. These proteins interact with p65 or cRel containing forms of NFkB and block nuclear import by masking the nuclear localisation sequences of NFkB. The activation of NFkB involves the inducible phosphorylation and subsequent degradation of IKB. Immunoblotting easily detects the hyperphosphorylated forms of IKB alpha, but not phosphorylated IKB beta. Interestingly, IKB alpha and IKB beta mediate different NFkB responses. IkB alpha appears to control more transient activation of NFkB in response to an inducer, while IKB beta controls a persistent response. Bcl3 interacts with p50 and p52 containing forms of NFkB, but rather than being an inhibitor it appears to function to stimulate transcription. The degradation of IKB is confirmed by immunoblotting.
Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity: IKB alpha Polyclonal Antibody detects endogenous levels of IKB alpha protein.
Molecular Weight: 37 kD
Note: For research use only, not for use in diagnostic procedure.
Alternative Names: NFKBIA; Inhibitor of KB alpha; I kappa B alpha; I (Kappa) B (alpha) ; IkappaBalpha; IKBA; IKBalpha; MAD 3; MAD3; Major histocompatibility complex enhancer binding protein MAD3; NF kappa B inhibitor alpha; NFKBI; Nuclear factor of kappa light chain gene enhancer in B cells; Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha; IKBA_HUMAN.
Immunogen: KLH conjugated synthetic peptide derived from human NFKBIA:1-120/314
Conjugate: Unconjugated
Modification: Unmodification
Purification & Purity: affinity purified by Protein A
Pathway: